The signaling networks of the herpesvirus entry mediator (TNFRSF14) in immune regulation.
Immunol Rev
; 244(1): 169-87, 2011 Nov.
Article
em En
| MEDLINE
| ID: mdl-22017438
ABSTRACT
The tumor necrosis factor (TNF) receptor superfamily member herpesvirus entry mediator (HVEM) (TNFRSF14) regulates T-cell immune responses by activating both inflammatory and inhibitory signaling pathways. HVEM acts as both a receptor for the canonical TNF-related ligands, LIGHT [lymphotoxin-like, exhibits inducible expression, and competes with herpes simplex virus glycoprotein D for HVEM, a receptor expressed on T lymphocytes] and lymphotoxin-α, and as a ligand for the immunoglobulin superfamily proteins BTLA (B and T lymphocyte attenuator) and CD160, a feature distinguishing HVEM from other immune regulatory molecules. The ability of HVEM to interact with multiple ligands in distinct configurations creates a functionally diverse set of intrinsic and bidirectional signaling pathways that control both inflammatory and inhibitory responses. The HVEM system is integrated into the larger LTßR and TNFR network through extensive shared ligand and receptor usage. Experimental mouse models and human diseases indicate that dysregulation of HVEM network may contribute to autoimmune pathogenesis, making it an attractive target for drug intervention.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Linfócitos T
/
Transdução de Sinais
/
Linfotoxina-alfa
/
Herpesvirus Humano 1
/
Membro 14 da Superfamília de Ligantes de Fatores de Necrose Tumoral
/
Membro 14 de Receptores do Fator de Necrose Tumoral
/
Herpes Simples
/
Imunidade Inata
Tipo de estudo:
Prognostic_studies
Idioma:
En
Revista:
Immunol Rev
Ano de publicação:
2011
Tipo de documento:
Article
País de afiliação:
Estados Unidos